Research and Markets has announced the addition of the "Top 10 Cellular Analysis Market - Global Forecast to 2021" report to their offering.

The top 10 cellular analysis market is expected to reach USD 41.34 Billion by 2021 from USD 28.66 Billion in 2016, at a CAGR of 7.6% during the forecast period.

Factors such as increasing government support in the form of funding in cell biology-based research, growing biotechnology industry, increasing prevalence of chronic and infectious diseases, and rising number of cancer cases are driving the growth of the top 10 cellular analysis market.

The top 10 cellular analysis market is categorized based on technology, application, end user, and region. The technology segments include cell imaging techniques, cell counting, flow cytometry, polymerase chain reaction (PCR), spectrophotometry, blotting, sample preparation technologies, high-content screening, centrifugation, and cell microarray technology. The cell imaging techniques segment is expected to account for the largest share of the top 10 cellular analysis market in 2016. Factors such as the rising incidence of diseases such as cancer, growing investments in cell biology research, and new product launches are driving the growth of this market.

On the basis of application, the top 10 cellular analysis market is categorized into biopharmaceutical applications, cancer research, stem cell research, tissue engineering and regenerative medicine, and other applications (virology, organ cultures, IVF, in vitro diagnostics, and genetic counselling). In 2016, the biopharmaceutical applications segment is expected to account for the largest share of the top 10 cellular analysis market. The increasing adoption of cell analysis technologies for the isolation of biomolecules is the key factor driving the growth of this application segment.

The end-user segments of the top 10 cellular analysis market include hospitals and diagnostic laboratories, biotechnology and pharmaceutical companies, research laboratories and institutes, cell banks, and other end users (blood banks, food and beverage manufacturers, environmental monitoring organizations, and forensic laboratories). The hospitals and diagnostic laboratories segment is expected to account for the largest share of the top 10 cellular analysis market in 2016. Factors such as increasing investments in healthcare systems and high prevalence of infectious and chronic diseases are driving the growth of the hospitals and diagnostic laboratories segment.

Companies Mentioned:

  • Agilent Technologies, Inc.
  • Beckman Coulter Inc. (A Subsidiary of Danaher Corporation)
  • Becton, Dickinson And Company
  • Bio-Rad Laboratories, Inc.
  • Ge Healthcare
  • Merck Kgaa
  • Nikon Corporation
  • Olympus Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Global Top 10 Cellular Analysis Market, By Technology

8 Top 10 Cellular Analysis Market, By Application

9 Top 10 Cellular Analysis Market, By End User

10 Global Top 10 Cellular Analysis Market, By Region

11 Competitive Landscape

12 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/7vd4x8/top_10_cellular